extended-release and long-acting opioid analgesics

Published on:
Thursday, April 20, 2017

The ACCME submitted a letter to Sen. McCaskill, Ranking Member, Committee on Homeland Security and Governmental Affairs, to address her investigation of the opioid epidemic. In the letter, Graham McMahon, MD, MMSc, President and...

Meeting Describes Value of CE in Supporting FDA REMS

Kate Regnier, MA, MBA, Executive Vice President, ACCME, attended the joint meeting of the Conjoint Committee on Continuing...

The ACCME has released a data report showing the scope of continuing...

Physician Leaders Address Role of CE in REMS

Kim Edward LeBlanc, MD, PhD, Chair, ACCME Board of Directors; Victor Reus, MD, Vice Chair, ACCME Board of Directors; and Graham McMahon,...

ACCME Data Shows Scope of CE on ER/LA Opioid REMS

The ACCME has released a ...

Promoting Public Health with Accredited Continuing Education

“We share the deep concerns of the FDA about the growing epidemic of opioid abuse, addiction, and overdose – and we are committed to leveraging...

Report Shows REMS-Compliant CE Activities Reach 70,000 Healthcare Professionals

The ACCME has released a ...

The ACCME submitted a letter to Sen. McCaskill, Ranking Member,...